April 22, 2026 05:43 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Will never forget’: Nation remembers Pahalgam victims as leaders vow strong fight against terror | 'India will never bow to any form of terror': PM Modi on Pahalgam terror attack anniversary | TCS Nashik case: No interim bail for Danish Shaikh in religious sentiments case | US woman alleges sexual assault at Karnataka homestay; owner among 2 arrested | ‘PM Modi is a terrorist’: Mallikarjun Kharge sparks row; BJP hits back | ‘What kind of order is this?’: Mamata slams ECI’s bike curbs in poll-bound Bengal, calls it ‘mischief’ | ‘90% of women can’t do politics without entering male politicians’ rooms’: Pappu Yadav sparks row; BJP targets Congress | Tim Cook to step down as Apple CEO; John Ternus named successor | 15 killed, 20 injured as bus plunges into gorge in J&K’s Udhampur | Oil jumps over 5% as Strait of Hormuz closure fuels supply fears
Serum Institute
PIB

Had a good interaction with team: Indian PM Narendra Modi tweets after visiting Serum Institute of India

| @indiablooms | Nov 29, 2020, at 12:38 am

Pune: Indian PM Narendra Modi on Saturday visited Pune's Serum Institute of India, which is working on the coronavirus vaccine, and interacted with the team at the Institute.

"They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing," read a government statement.

In a tweet, the Prime Minister said, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."  

The institute's CEO Adar Poonawala thannked PM and tweeted: "Thank you @narendramodi for visiting @SerumInstIndia . We share your vision and continue to work towards ensuring a safe and secure India."

The PM earlier in the day visited  Bharat Biotech International Limited (BBIL) at Genome Valley in Shamirpet and reviewed the progress on the manufacturing of indigenous COVID-19 vaccine 'Covaxin'.

In Ahmedabad, he reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.